why choose us

First received: October 20, 2023

Clinical Trial: A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Autism Spectrum Disorder

Study Type: INTERVENTIONAL


Official Title: A Blinded, Cross-Over Study to Evaluate the Safety and Efficacy of ARD-501 in Patients With Autism Spectrum Disorder

Brief Summary: This is a blinded, placebo controlled, cross-over trial evaluating the safety of two dose-levels of in subjects with ASD.

Read more